GlassScriptPhysician profile
Humair Khan
NPI 1447510615
$7,757.82
in general payments reported to CMS, 2019-2025
16 companies · $1,639 in 2025
The $1,639 reported for 2025 was more than what 86% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $26.69 · 2021: $419 · 2022: $258 · 2023: $315 · 2024: $4,942 · 2025: $1,639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,238 · Travel and Lodging: $2,628 · Grant: $28.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,238.25 |
| Travel and Lodging | $2,628.25 |
| Grant | $28.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $2,587.84 | 2024 | Visumax, Cirrus Hd-Oct, Veracity Surgical |
| Lensar, INC. | $1,401.07 | 2024 | Lensar Laser System |
| Biotissue Holdings INC. | $1,032.00 | 2022-2025 | |
| Alcon Vision LLC | $844.95 | 2019-2025 | Clareon, Rocklatan, Acrysof Iq Panoptix Uv Iol |
| Glaukos Corporation | $687.44 | 2019-2024 | Ce-Marked Kxla System, Photrexa Cross-Linking Kit |
| Bausch & Lomb Americas INC. | $261.66 | 2023-2025 | Stellaris, Envista Mx60 Iol, Ic-8 Apthera Iol |
| Sight Sciences, INC. | $190.25 | 2022-2024 | Omni Surgical System |
| Abbvie INC. | $174.39 | 2024-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $172.03 | 2021-2025 | Catalys System, Tecnis Simplicity |
| Rxsight INC | $134.37 | 2024-2025 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Dompe US, INC. | $61.89 | 2025 | Oxervate |
| Mallinckrodt Hospital Products INC. | $56.90 | 2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $55.56 | 2025 | |
| Amgen INC. | $43.67 | 2025 | Tepezza |
| Boston Scientific Corporation | $28.91 | 2023 | Resolution 360 Ultra Clip |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $24.89 | 2025 | Tyrvaya, Ryzumvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Humair Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.